| Clinical significance: |
Diagnostic value in gastric cancer tissues and plasma (AUC 0.658 in tissues, 0.747 in plasma; combined AUC 0.824). Lower levels correlate with clinicopathological indicators (e.g., CEA, CA19-9, lymph node metastasis, distant metastasis). |
| Description: |
hsa_circ_0001811 is significantly down-regulated in gastric cancer tissues and in preoperative patient plasma. Its tissue and plasma levels show diagnostic utility by ROC analysis, and lower expression is associated with several clinicopathological features, supporting its potential as a non-invasive diagnostic biomarker. |